Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy

Area of Science:

• Neurology
• Immunology
• Infectious Diseases

Background:

• Progressive multifocal leukoencephalopathy (PML) typically presents with minimal inflammation.
• Immune reconstitution inflammatory syndrome (IRIS) can cause an inflammatory response in PML patients.
• Understanding PML-IRIS characteristics is crucial for patient management.

Purpose of the Study:

• To investigate how immune reconstitution inflammatory syndrome (IRIS) affects the characteristics and outcomes of progressive multifocal leukoencephalopathy (PML).

Main Methods:

• Retrospective review of 87 patients diagnosed with PML.
• Analysis of 27 patients with PML-IRIS.
• Comparison of MRI findings, CD4 counts, cerebrospinal fluid (CSF) parameters, and survival rates between PML and PML-IRIS groups.

Main Results:

• Gadolinium enhancement on MRI was significantly higher in PML-IRIS (44.4%) compared to PML (5.1%), indicating low diagnostic utility.
• Lower CD4 counts in HIV+ patients predicted the development of IRIS.
• Higher CSF white blood cell counts and protein levels correlated with improved prognosis, but MRI enhancement did not.
• No significant difference in survival was observed between PML and PML-IRIS groups.

Conclusions:

• PML-IRIS presents with distinct MRI characteristics, notably increased gadolinium enhancement.
• Lower CD4 counts are a key predictor for IRIS development in HIV-positive individuals with PML.
• While CSF markers indicate prognosis, MRI enhancement is not a reliable prognostic indicator for survival in PML or PML-IRIS.